We are live on ! Find out more
OCM

Orser Capital Management Portfolio holdings

AUM $202M
1-Year Est. Return 32.65%
This Fund
S&P 500
This Quarter Est. Return
+11.8%
1 Year Est. Return
+32.65%
3 Year Est. Return
+122.2%
5 Year Est. Return
+162.36%
10 Year Est. Return
AUM
$100M
AUM Growth
+$11.5M
Cap. Flow
+$2.24M
Cap. Flow %
2.23%
Top 10 Hldgs %
49.79%
Holding
54
New
3
Increased
15
Reduced
21
Closed
2

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$3.6M
2
BA icon
Boeing
BA
+$357K
3
PG icon
Procter & Gamble
PG
+$161K
4
MSFT icon
Microsoft
MSFT
+$87.8K
5
WM icon
Waste Management
WM
+$81K

Sector Composition

Rank Sector Weight
1 Technology 32.4%
2 Healthcare 13.04%
3 Consumer Staples 8.45%
4 Industrials 8.21%
5 Consumer Discretionary 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
51
UnitedHealth
UNH
$370B
$216K 0.22%
450
RSP icon
52
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$202K 0.2%
+1,350
New +$194K
BA icon
53
Boeing
BA
$185B
-1,681
Closed -$357K
EW icon
54
Edwards Lifesciences
EW
$51.7B
-43,461
Closed -$3.6M

Similar funds

Orser Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Orser Capital Management held 54 positions worth $100M, up 13% from $88.7M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Orser Capital Management's Q2 2023 filing shows 3 new, 15 increased, 21 reduced and 2 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,855 shares worth $756K. The largest sale was Edwards Lifesciences, an estimated $3.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Orser Capital Management's largest Q2 2023 buy was Vanguard S&P 500 ETF: 1,855 shares worth $756K.
  • Orser Capital Management added most to Air Products & Chemicals in Q2 2023, an estimated $1.19M increase.
  • Orser Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $161K.
  • Orser Capital Management fully exited Edwards Lifesciences in Q2 2023, selling an estimated $3.6M.
  • Orser Capital Management's ten largest holdings make up 50% of its $100M portfolio in Q2 2023.
  • Orser Capital Management opened 3 new positions and closed 2 in Q2 2023.
  • Orser Capital Management's portfolio value rose 13% quarter-over-quarter to $100M.

Based on Orser Capital Management's 13F filing for Q2 2023, filed 11 Jul 2023.